Skip to content

Alignment Healthcare ALHC Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Humana logo
HumanaHUM
UnitedHealth Group logo
UnitedHealth GroupUNH

Other financials

Income statement

See full
Revenue$1.2B+33.3%
Operating income$15.5M+387%
Net income$11.4M+225%
EPS (diluted)$0.05+200%

Balance sheet

See full
Cash & equivalents$707.7M+57.9%
Total debt$323.6M+0.5%
Total equity$206.9M+91.3%
Total assets$1.3B+40.9%

Cash flow

See full
Operating cash flow$128.7M+674%
CapEx$7.4M-10.8%
Free cash flow$121.3M+1,350%

Valuation

See full
Market cap$4.52B+0.8%

Profitability

See full
Operating margin0.1%0.0pp
Net margin0.5%+0.2pp
FCF margin4.1%

Returns & leverage

See full
Return on equity12.6%+6.8pp
Debt / equity1.6×-1.4×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Alignment Healthcare in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Alignment Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alignment Healthcare's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alignment Healthcare's convertible preferred stock authorized shares?
Alignment Healthcare (ALHC) reported convertible preferred stock authorized shares of 100M in Q1 2026.
How has Alignment Healthcare's convertible preferred stock authorized shares changed year-over-year?
Alignment Healthcare's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 100M to 100M.
What is the long-term trend for Alignment Healthcare's convertible preferred stock authorized shares?
Over 2 years (2023 to 2025), Alignment Healthcare's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 100M to 100M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.